Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 18008
2021 33905
2022 33084
2023 24151
2024 7721

Text availability

Article attribute

Article type

Publication date

Search Results

101,395 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients.
Najjar-Debbiny R, Gronich N, Weber G, Khoury J, Amar M, Stein N, Goldstein LH, Saliba W. Najjar-Debbiny R, et al. Clin Infect Dis. 2023 Feb 8;76(3):e342-e349. doi: 10.1093/cid/ciac443. Clin Infect Dis. 2023. PMID: 35653428 Free PMC article.
BACKGROUND: Paxlovid was granted an Emergency Use Authorization for the treatment of mild to moderate coronavirus disease 2019 (COVID-19), based on the interim analysis of the Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients (EPIC-H …
BACKGROUND: Paxlovid was granted an Emergency Use Authorization for the treatment of mild to moderate coronavirus disease 2019 (COVID …
Impact of COVID-19 on Cardiovascular Disease.
Vosko I, Zirlik A, Bugger H. Vosko I, et al. Viruses. 2023 Feb 11;15(2):508. doi: 10.3390/v15020508. Viruses. 2023. PMID: 36851722 Free PMC article. Review.
Until now, more than 670 million people have suffered from COVID-19 worldwide, and roughly 7 million death cases were attributed to COVID-19. Recent evidence suggests an interplay between COVID-19 and cardiovascular disease (CVD). COVI …
Until now, more than 670 million people have suffered from COVID-19 worldwide, and roughly 7 million death cases were attribut …
Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review.
Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Joshi A, et al. Front Public Health. 2021 Aug 13;9:698111. doi: 10.3389/fpubh.2021.698111. eCollection 2021. Front Public Health. 2021. PMID: 34485229 Free PMC article. Review.
COVID-19 vaccine is regarded as the most promising means of limiting the spread of or eliminating the pandemic. The success of this strategy will rely on the rate of vaccine acceptance globally. The study aims to examine the factors that influence COVID-19 …
COVID-19 vaccine is regarded as the most promising means of limiting the spread of or eliminating the pandemic. The success of …
COVID-19: Brain Effects.
Dix E, Roy K. Dix E, et al. Psychiatr Clin North Am. 2022 Dec;45(4):625-637. doi: 10.1016/j.psc.2022.07.009. Epub 2022 Jul 6. Psychiatr Clin North Am. 2022. PMID: 36396269 Free PMC article. Review.
The vulnerability of the brain with aging further increases the burden of disease in the elderly, who are at the highest risk of complications and death from COVID-19. The mechanisms underlying the effects of COVID-19 on the brain are not fully known. …
The vulnerability of the brain with aging further increases the burden of disease in the elderly, who are at the highest risk of complicatio …
COVID-19 and Inflammatory Markers.
Balta S, Balta I. Balta S, et al. Curr Vasc Pharmacol. 2022;20(4):326-332. doi: 10.2174/1570161120666220404200205. Curr Vasc Pharmacol. 2022. PMID: 35379133 Review.
Coronavirus disease-2019 (COVID-19) causes mild illness to serious infection with lung involvement, thrombosis, and other complications potentially resulting in fatal outcomes. ...This brief narrative review assesses the relationship between these inflammatory marke …
Coronavirus disease-2019 (COVID-19) causes mild illness to serious infection with lung involvement, thrombosis, and other comp …
Neuropathology of COVID-19.
Lin LC, Hollis B, Hefti MM. Lin LC, et al. Indian J Pathol Microbiol. 2022 May;65(Supplement):S146-S152. doi: 10.4103/ijpm.ijpm_1103_21. Indian J Pathol Microbiol. 2022. PMID: 35562145 Free article. Review.
The current data on the neuropathology of COVID-19 remains preliminary and is limited by the lack of suitable controls, but certain tentative conclusions can be drawn. ...There is also intriguing preliminary data to suggest a complex relationship between COVID …
The current data on the neuropathology of COVID-19 remains preliminary and is limited by the lack of suitable controls, but ce …
Sarcopenia and COVID-19 Outcomes.
Wang Y, Tan S, Yan Q, Gao Y. Wang Y, et al. Clin Interv Aging. 2023 Mar 9;18:359-373. doi: 10.2147/CIA.S398386. eCollection 2023. Clin Interv Aging. 2023. PMID: 36923269 Free PMC article. Review.
Coronavirus disease 2019 (COVID-19) spread rapidly and became a severe global public health threat. ...This review aimed to analyze the current reports on the association between sarcopenia and COVID-19 and provide an update on the contribution of sarc …
Coronavirus disease 2019 (COVID-19) spread rapidly and became a severe global public health threat. ...This review aimed to an …
The Implications of COVID-19 to Ophthalmology.
Lai THT, Tang EWH, Li KKW. Lai THT, et al. Adv Exp Med Biol. 2021;1318:637-655. doi: 10.1007/978-3-030-63761-3_35. Adv Exp Med Biol. 2021. PMID: 33973203 Review.
At least 16 ophthalmologists worldwide have succumbed to COVID-19. It reflects the susceptibility of ophthalmologists to COVID-19 infection as they are in close proximity to patients. This chapter provides an overview of the ocular manifestations of …
At least 16 ophthalmologists worldwide have succumbed to COVID-19. It reflects the susceptibility of ophthalmologists to CO …
Systematic Mendelian randomization study of the effect of gut microbiome and plasma metabolome on severe COVID-19.
Yan H, Zhao S, Huang HX, Xie P, Cai XH, Qu YD, Zhang W, Luo JQ, Zhang L, Li X. Yan H, et al. Front Immunol. 2023 Aug 16;14:1211612. doi: 10.3389/fimmu.2023.1211612. eCollection 2023. Front Immunol. 2023. PMID: 37662924 Free PMC article.
BACKGROUND: COVID-19 could develop severe respiratory symptoms in certain infected patients, especially in the patients with immune disorders. Gut microbiome and plasma metabolome act important immunological modulators in the human body and could contribute to the i …
BACKGROUND: COVID-19 could develop severe respiratory symptoms in certain infected patients, especially in the patients with i …
COVID-19 in cancer patients.
Seneviratne SL, Wijerathne W, Yasawardene P, Somawardana B. Seneviratne SL, et al. Trans R Soc Trop Med Hyg. 2022 Sep 10;116(9):767-797. doi: 10.1093/trstmh/trac015. Trans R Soc Trop Med Hyg. 2022. PMID: 35276734 Free PMC article.
The complex interplay of immune dysfunction, active malignancy, the effect of cancer treatment on the immune system and additional comorbidities associated with cancer and COVID-19 all affect the outcomes of COVID-19 in patients with cancer. We have di …
The complex interplay of immune dysfunction, active malignancy, the effect of cancer treatment on the immune system and additional comorbidi …
101,395 results
You have reached the last available page of results. Please see the User Guide for more information.